helios medical communications limitedEstimated Valuation
£23.4m
Pomanda estimates the enterprise value of HELIOS MEDICAL COMMUNICATIONS LIMITED at £23.4m based on a Turnover of £18.7m and 1.26x industry multiple (adjusted for size and gross margin).
helios medical communications limitedEstimated Valuation
£37.5m
Pomanda estimates the enterprise value of HELIOS MEDICAL COMMUNICATIONS LIMITED at £37.5m based on an EBITDA of £4.4m and a 8.6x industry multiple (adjusted for size and gross margin).
helios medical communications limitedEstimated Valuation
£35.3m
Pomanda estimates the enterprise value of HELIOS MEDICAL COMMUNICATIONS LIMITED at £35.3m based on Net Assets of £15.8m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Helios Medical Communications LimitedOverview
Helios Medical Communications Limited is a live company located in macclesfield, SK10 4TG with a Companies House number of 09741350. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in August 2015, it's largest shareholder is
project ocean bidco limited
with a 100% stake. Helios Medical Communications Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£18.7m with
healthy
growth in recent years.
Helios Medical Communications Limited Health Check
Pomanda's financial health check has awarded Helios Medical Communications Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
8 Strong
1 Regular
3 Weak
Size
annual sales of £18.7m, make it larger than the average company (£2.9m)
£18.7m - Helios Medical Communications Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (7.2%)
9% - Helios Medical Communications Limited
7.2% - Industry AVG
Production
with a gross margin of 91.3%, this company has a lower cost of product (45%)
91.3% - Helios Medical Communications Limited
45% - Industry AVG
Profitability
an operating margin of 22.6% make it more profitable than the average company (5.6%)
22.6% - Helios Medical Communications Limited
5.6% - Industry AVG
Employees
with 197 employees, this is above the industry average (23)
197 - Helios Medical Communications Limited
23 - Industry AVG
Pay Structure
on an average salary of £55.7k, the company has an equivalent pay structure (£54k)
£55.7k - Helios Medical Communications Limited
£54k - Industry AVG
Efficiency
resulting in sales per employee of £94.8k, this is less efficient (£125.4k)
£94.8k - Helios Medical Communications Limited
£125.4k - Industry AVG
Debtor Days
it gets paid by customers after 120 days, this is later than average (56 days)
120 days - Helios Medical Communications Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (31 days)
0 days - Helios Medical Communications Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 1 days, this is less than average (30 days)
1 days - Helios Medical Communications Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 58 weeks, this is more cash available to meet short term requirements (24 weeks)
58 weeks - Helios Medical Communications Limited
24 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 25.4%, this is a lower level of debt than the average (53.3%)
25.4% - Helios Medical Communications Limited
53.3% - Industry AVG
HELIOS MEDICAL COMMUNICATIONS LIMITED financials
EXPORT
Helios Medical Communications Limited's latest turnover from December 2023 is £18.7 million and the company has net assets of £15.8 million. According to their latest financial statements, Helios Medical Communications Limited has 197 employees and maintains cash reserves of £6 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Turnover
18,675,230
15,540,276
15,749,952
14,553,331
10,973,663
11,724,643
6,370,526
2,115,245
Other Income Or Grants
Cost Of Sales
1,618,140
998,441
1,247,222
2,711,939
1,779,717
6,649,774
3,546,288
1,120,359
Gross Profit
17,057,090
14,541,835
14,502,730
11,841,392
9,193,946
5,074,869
2,824,239
994,886
Admin Expenses
12,846,171
9,972,200
8,638,615
6,205,732
4,674,379
3,045,878
1,729,603
634,744
Operating Profit
4,210,919
4,569,635
5,864,115
5,635,660
4,519,567
2,028,991
1,094,636
360,142
Interest Payable
1,355
4,157
Interest Receivable
63,259
2,504
36
7,129
14,844
23,249
6,581
872
Pre-Tax Profit
4,274,178
4,572,139
5,862,796
5,642,789
4,530,254
2,052,240
1,101,217
361,014
Tax
-937,537
-712,099
-217,021
-1,080,312
-873,407
-389,926
-209,231
-72,203
Profit After Tax
3,336,641
3,860,040
5,645,775
4,562,477
3,656,847
1,662,314
891,986
288,811
Dividends Paid
6,778,915
1,500,000
Retained Profit
3,336,641
3,860,040
-1,133,140
4,562,477
2,156,847
1,662,314
891,986
288,811
Employee Costs
10,979,993
8,394,035
7,663,013
5,565,223
4,146,655
1,942,790
892,889
307,141
Number Of Employees
197
156
124
87
60
42
20
7
EBITDA*
4,366,327
4,703,385
5,960,566
5,705,171
4,562,007
2,049,647
1,107,897
363,074
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Tangible Assets
347,740
297,795
368,854
206,906
69,693
51,816
48,613
10,303
Intangible Assets
Investments & Other
100
100
100
Debtors (Due After 1 year)
Total Fixed Assets
347,840
297,895
368,954
206,906
69,693
51,816
48,613
10,303
Stock & work in progress
5,561
112,596
71,683
78,809
1,050,478
621,982
553,992
94,415
Trade Debtors
6,156,580
5,591,488
5,349,493
3,598,902
2,132,566
3,415,958
1,929,169
577,799
Group Debtors
8,000,120
7,391,265
2,451,765
Misc Debtors
659,062
1,058,560
1,484,174
435,450
281,952
83,195
26,061
14,168
Cash
5,979,513
2,173,629
2,988,328
9,132,339
6,599,380
4,264,942
1,934,690
697,719
misc current assets
total current assets
20,800,836
16,327,538
12,345,443
13,245,500
10,064,376
8,386,077
4,443,912
1,384,101
total assets
21,148,676
16,625,433
12,714,397
13,452,406
10,134,069
8,437,893
4,492,525
1,394,404
Bank overdraft
Bank loan
Trade Creditors
2,056
157,264
109,469
79,478
85,572
60,277
37,130
31,095
Group/Directors Accounts
635,119
other short term finances
hp & lease commitments
other current liabilities
4,708,222
3,998,246
3,987,488
3,640,677
4,890,189
5,377,892
3,120,179
922,337
total current liabilities
5,345,397
4,155,510
4,096,957
3,720,155
4,975,761
5,438,169
3,157,309
953,432
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
32,064
35,349
42,906
19,716
8,250
6,513
4,319
2,061
total long term liabilities
32,064
35,349
42,906
19,716
8,250
6,513
4,319
2,061
total liabilities
5,377,461
4,190,859
4,139,863
3,739,871
4,984,011
5,444,682
3,161,628
955,493
net assets
15,771,215
12,434,574
8,574,534
9,712,535
5,150,058
2,993,211
1,330,897
438,911
total shareholders funds
15,771,215
12,434,574
8,574,534
9,712,535
5,150,058
2,993,211
1,330,897
438,911
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Operating Activities
Operating Profit
4,210,919
4,569,635
5,864,115
5,635,660
4,519,567
2,028,991
1,094,636
360,142
Depreciation
155,408
133,750
96,451
69,511
42,440
20,656
13,261
2,932
Amortisation
Tax
-937,537
-712,099
-217,021
-1,080,312
-873,407
-389,926
-209,231
-72,203
Stock
-107,035
40,913
-7,126
-971,669
428,496
67,990
459,577
94,415
Debtors
774,449
4,755,881
5,251,080
1,619,834
-1,084,635
1,543,923
1,363,263
591,967
Creditors
-155,208
47,795
29,991
-6,094
25,295
23,147
6,035
31,095
Accruals and Deferred Income
709,976
10,758
346,811
-1,249,512
-487,703
2,257,713
2,197,842
922,337
Deferred Taxes & Provisions
-3,285
-7,557
23,190
11,466
1,737
2,194
2,258
2,061
Cash flow from operations
3,312,859
-754,512
899,583
2,732,554
3,884,068
2,330,862
1,281,961
559,982
Investing Activities
capital expenditure
-205,353
-62,691
-258,399
-23,859
-51,571
-13,235
Change in Investments
100
cash flow from investments
-205,353
-62,691
-258,499
-23,859
-51,571
-13,235
Financing Activities
Bank loans
Group/Directors Accounts
635,119
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-4,861
150,100
interest
63,259
2,504
-1,319
7,129
10,687
23,249
6,581
872
cash flow from financing
698,378
2,504
-6,180
7,129
10,687
23,249
6,581
150,972
cash and cash equivalents
cash
3,805,884
-814,699
-6,144,011
2,532,959
2,334,438
2,330,252
1,236,971
697,719
overdraft
change in cash
3,805,884
-814,699
-6,144,011
2,532,959
2,334,438
2,330,252
1,236,971
697,719
helios medical communications limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for helios medical communications limited. Get real-time insights into helios medical communications limited's credit score, group structure and payment trends.
Helios Medical Communications Limited Competitor Analysis
Perform a competitor analysis for helios medical communications limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in SK10 area or any other competitors across 12 key performance metrics.
helios medical communications limited Ownership
HELIOS MEDICAL COMMUNICATIONS LIMITED group structure
Helios Medical Communications Limited has 2 subsidiary companies.
HELIOS MEDICAL COMMUNICATIONS LIMITED Shareholders
The sole shareholder of Helios Medical Communications Limited is Project Ocean Bidco Limited.
project ocean bidco limited
100%
helios medical communications limited directors
Helios Medical Communications Limited currently has 3 directors.
The longest serving directors include
Mr Andrew Minnock (Aug 2015) and
Mr Simon Whiteley (Aug 2015).
the biohub at alderley park, alderley park, macclesfield, cheshire, SK10 4TG
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
helios medical communications limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to helios medical communications limited. Currently there are 3 open charges and 0 have been satisfied in the past.
helios medical communications limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HELIOS MEDICAL COMMUNICATIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
helios medical communications limitedCompanies House Filings - See Documents
